Cancer Research Institute Technology Impact Award - LOI

Sponsor Deadline: 

Nov 15, 2021

Letter of Intent Deadline: 

Nov 15, 2021


Cancer Research Institute CRI

UI Contact: 

Cancer Research Institute Technology Impact Award
provides seed funding of up to $200,000 to be used over 12-24 months to address the gap between technology development and clinical application of cancer immunotherapies. These grants aim to encourage collaboration between technology developers and clinical cancer immunologists and to generate the proof-of-principle of a novel platform technology in bioinformatics, ex vivo or in silico modeling systems, immunological or tumor profiling instrumentation, methods, reagents and assays, or other relevant technologies that can enable clinician scientists to generate deeper insights into the mechanisms of action of effective or ineffective cancer immunotherapies.

Required LOI due November 15, 2021.